These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32949960)

  • 41. Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors.
    Piton J; Foo CS; Cole ST
    Drug Discov Today; 2017 Mar; 22(3):526-533. PubMed ID: 27666194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.
    Landge S; Mullick AB; Nagalapur K; Neres J; Subbulakshmi V; Murugan K; Ghosh A; Sadler C; Fellows MD; Humnabadkar V; Mahadevaswamy J; Vachaspati P; Sharma S; Kaur P; Mallya M; Rudrapatna S; Awasthy D; Sambandamurthy VK; Pojer F; Cole ST; Balganesh TS; Ugarkar BG; Balasubramanian V; Bandodkar BS; Panda M; Ramachandran V
    Bioorg Med Chem; 2015 Dec; 23(24):7694-710. PubMed ID: 26643218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DprE1 Inhibitors: Enduring Aspirations for Future Antituberculosis Drug Discovery.
    Yadav S; Soni A; Tanwar O; Bhadane R; Besra GS; Kawathekar N
    ChemMedChem; 2023 Aug; 18(16):e202300099. PubMed ID: 37246503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lead optimization of 1,4-azaindoles as antimycobacterial agents.
    Shirude PS; Shandil RK; Manjunatha MR; Sadler C; Panda M; Panduga V; Reddy J; Saralaya R; Nanduri R; Ambady A; Ravishankar S; Sambandamurthy VK; Humnabadkar V; Jena LK; Suresh RS; Srivastava A; Prabhakar KR; Whiteaker J; McLaughlin RE; Sharma S; Cooper CB; Mdluli K; Butler S; Iyer PS; Narayanan S; Chatterji M
    J Med Chem; 2014 Jul; 57(13):5728-37. PubMed ID: 24874895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.
    Shirude PS; Shandil R; Sadler C; Naik M; Hosagrahara V; Hameed S; Shinde V; Bathula C; Humnabadkar V; Kumar N; Reddy J; Panduga V; Sharma S; Ambady A; Hegde N; Whiteaker J; McLaughlin RE; Gardner H; Madhavapeddi P; Ramachandran V; Kaur P; Narayan A; Guptha S; Awasthy D; Narayan C; Mahadevaswamy J; Vishwas KG; Ahuja V; Srivastava A; Prabhakar KR; Bharath S; Kale R; Ramaiah M; Choudhury NR; Sambandamurthy VK; Solapure S; Iyer PS; Narayanan S; Chatterji M
    J Med Chem; 2013 Dec; 56(23):9701-8. PubMed ID: 24215368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex.
    Sammartino JC; Morici M; Stelitano G; Degiacomi G; Riccardi G; Chiarelli LR
    Biochem Biophys Res Commun; 2022 Jun; 607():49-53. PubMed ID: 35366543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DprE1--from the discovery to the promising tuberculosis drug target.
    Mikusová K; Makarov V; Neres J
    Curr Pharm Des; 2014; 20(27):4379-403. PubMed ID: 24245764
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Borthwick JA; Alemparte C; Wall I; Whitehurst BC; Argyrou A; Burley G; de Dios-Anton P; Guijarro L; Monteiro MC; Ortega F; Suckling CJ; Pichel JC; Cacho M; Young RJ
    J Med Chem; 2020 Mar; 63(5):2557-2576. PubMed ID: 31922409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents.
    Samoon R; Sau S; Roy A; Parida KK; Sharma K; Yakkala PA; Dewangan RP; Abdin MZ; Kalia NP; Shafi S
    ACS Infect Dis; 2024 Sep; 10(9):3320-3331. PubMed ID: 39150887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis.
    Crellin PK; Brammananth R; Coppel RL
    PLoS One; 2011 Feb; 6(2):e16869. PubMed ID: 21346818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
    Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
    ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.
    R MM; Shandil R; Panda M; Sadler C; Ambady A; Panduga V; Kumar N; Mahadevaswamy J; Sreenivasaiah M; Narayan A; Guptha S; Sharma S; Sambandamurthy VK; Ramachandran V; Mallya M; Cooper C; Mdluli K; Butler S; Tommasi R; Iyer PS; Narayanan S; Chatterji M; Shirude PS
    ACS Med Chem Lett; 2019 Oct; 10(10):1480-1485. PubMed ID: 31620237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis.
    Imran M; Khan SA; Asdaq SMB; Almehmadi M; Abdulaziz O; Kamal M; Alshammari MK; Alsubaihi LI; Hussain KH; Alharbi AS; Alzahrani AK
    J Infect Public Health; 2022 Oct; 15(10):1097-1107. PubMed ID: 36122509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of novel anti-tuberculosis agent: An in silico investigation.
    Vasava M; Thacker S; Jethwa D; Acharya P; Bhavsar Z; Patel H
    Indian J Tuberc; 2022 Oct; 69(4):503-522. PubMed ID: 36460382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
    Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting decaprenylphosphoryl-β-D-ribose 2'-epimerase for Innovative Drug Development Against Mycobacterium Tuberculosis Drug-Resistant Strains.
    El Haddoumi G; Mansouri M; Kourou J; Belyamani L; Ibrahimi A; Kandoussi I
    Bioinform Biol Insights; 2024; 18():11779322241257039. PubMed ID: 38812740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
    Naik M; Humnabadkar V; Tantry SJ; Panda M; Narayan A; Guptha S; Panduga V; Manjrekar P; Jena LK; Koushik K; Shanbhag G; Jatheendranath S; Manjunatha MR; Gorai G; Bathula C; Rudrapatna S; Achar V; Sharma S; Ambady A; Hegde N; Mahadevaswamy J; Kaur P; Sambandamurthy VK; Awasthy D; Narayan C; Ravishankar S; Madhavapeddi P; Reddy J; Prabhakar K; Saralaya R; Chatterji M; Whiteaker J; McLaughlin B; Chiarelli LR; Riccardi G; Pasca MR; Binda C; Neres J; Dhar N; Signorino-Gelo F; McKinney JD; Ramachandran V; Shandil R; Tommasi R; Iyer PS; Narayanan S; Hosagrahara V; Kavanagh S; Dinesh N; Ghorpade SR
    J Med Chem; 2014 Jun; 57(12):5419-34. PubMed ID: 24871036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DprE1 and Ddn as promising therapeutic targets in the development of novel anti-tuberculosis nitroaromatic drugs.
    Paoli-Lombardo R; Primas N; Vanelle P
    Eur J Med Chem; 2024 Aug; 274():116559. PubMed ID: 38850856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes.
    Liu R; Lyu X; Batt SM; Hsu MH; Harbut MB; Vilchèze C; Cheng B; Ajayi K; Yang B; Yang Y; Guo H; Lin C; Gan F; Wang C; Franzblau SG; Jacobs WR; Besra GS; Johnson EF; Petrassi M; Chatterjee AK; Fütterer K; Wang F
    Angew Chem Int Ed Engl; 2017 Oct; 56(42):13011-13015. PubMed ID: 28815830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.